Emraclidine was expected to be a blockbuster drug for AbbVie, and this development didn’t sit well with investors.

Schrödinger Inc.’s stock soared 14% Tuesday to put in on track for its biggest one-day gain in a year, after the company said ...

Shares have retreated in Asia after a lackluster finish on Wall Street following a report showing an uptick in inflation in ...

The SPDR S&P Bank ETF (KBE) shows a 0.4% decline and the SPDR S&P Regional Banking ETF (KRE) trades 0.5% lower. The S&P 500 financial sector shows a 0.4% decline. [BRIEFING.COM] The stock market ...

Sheldon Cooper / SOPA Images / LightRocket via ... than four years Wednesday. United stock jumped more than 12% in the prior session after it announced a $1.5 billion share buyback, its first ...

An investor who purchased just $1,000 worth of the stock back then would have $28,000 ... which ran from Oct. 7 to Oct. 9, as an opportunity to stoke optimism about its hardware business.

WASHINGTON, DC - SEPTEMBER 27: NVIDIA founder, President and CEO Jensen Huang speaks about the ... [+] future of artificial intelligence and its effect on energy consumption and production at the ...

Third-quarter earnings for the cruise line rose 15% year over year to a record $7.9 billion, driven primarily ... the cruise ...

Roku Inc.’s stock ... 5% in after-hours trade Wednesday, after the streaming platform posted another quarterly loss and flat average revenue per user. Roku ROKU posted a third-quarter net loss ...

The pipeline company generated nearly $1.9 billion of adjusted earnings before ... while its gathering volumes grew by 5%, due to higher production in the Haynesville and Eagle Ford regions.

Beata Zawrzel / NurPhoto via Getty Images U.S. stock ... to know today. U.S. stock futures are pointing mostly higher to end the week, with the Nasdaq rising by 0.5% as Netflix (NFLX) helps ...